Insmed Inc (INSM)
69.61
-1.06
(-1.50%)
USD |
NASDAQ |
Dec 27, 16:00
69.65
+0.04
(+0.06%)
After-Hours: 20:00
Insmed Research and Development Expense (Quarterly): 150.81M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 270.93M |
| Cytokinetics Inc | -- |
| Amicus Therapeutics Inc | 26.16M |
| Ocugen Inc | 8.108M |
| Krystal Biotech Inc | 13.51M |